RTV: Clinical Trials

10 trials of RTV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 terminated. 10 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 9, Terminated 1
Phase 11Completed 1

Follow RTV: new trials by email Literature Review of RTV trials Research Report on RTV

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection
GLS4, RTV, ETV - Chronic HBV Infection
Phase 2CompletedSunshine Lake Pharma Co., Ltd.2502019-02-282024-06-21
Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus
GS-9131, BIC, TAF - HIV-1-infection
Phase 2TerminatedGilead Sciences212018-04-032021-01-05
The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules
GLS4, RTV - Chronic Hepatitis B
Phase 2CompletedSunshine Lake Pharma Co., Ltd.202017-07-262020-07-23
Lonafarnib With and Without Ritonavir in HDV (LOWR-1)
lonafarnib, peginterferon alfa-2a, ritonavir - Chronic Hepatitis D Infection
Phase 2CompletedEIT Pharma, Inc.212014-11-012026-09-25
Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen
Darunavir, Ritonavir, Tenofovir disoproxil fumarate - HIV-1 Infection
Phase 2CompletedAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections2622012-01-172024-10-15
A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents
darunavir, ritonavir, zidovudine - HIV-1 Infection
Phase 2CompletedTibotec Pharmaceuticals, Ireland122009-07-012012-09-03
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
COBI, RTV, ATV - HIV-1 Infection
Phase 2CompletedGilead Sciences852009-05-012016-02-15
Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection
EVG, RTV, ARV regimen - HIV Infections
Phase 2CompletedGilead Sciences1922007-02-012016-04-25
Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children
Atazanavir, Darunavir, Efavirenz - HIV Infections
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)752006-02-012021-11-09
A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials
TMC114, rtv - HIV
Phase 2CompletedTibotec Pharmaceuticals, Ireland522005-01-012014-08-25

Conditions studied

HIV Infections (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Hepatitis B, Chronic (1)

Sponsors

Gilead Sciences (3)  ·  Sunshine Lake Pharma Co., Ltd. (2)  ·  Tibotec Pharmaceuticals, Ireland (2)  ·  Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1)  ·  EIT Pharma, Inc. (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (5)  ·  Puerto Rico (3)  ·  China (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Poland (1)  ·  Russia (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)

Top investigators

Babafemi Taiwo, MBBS, MD (1)  ·  Cihan Yurdaydin, MD (1)  ·  Jennifer King, PharmD (1)  ·  Junqi Niu, doctor (1)  ·  Marshall Fordyce, MD (1)  ·  Martin Rhee, MD (1)  ·  Ram Yogev, MD (1)

Results publications

PMID 21811136, PMID 26060295, PMID 39988055

NIH funding

2008 (1), U01AI068636 (1)